title: Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
abstract: OBJECTIVE
  Young patients with moyamoya disease frequently exhibit extensive cerebral infarction at the time of initial presentation, and even in the early postoperative period. To investigate clinical characteristics in the early postoperative period, the authors prospectively analyzed findings of MR imaging, MR angiography, and SPECT before and after surgery. The authors focused in particular on how postoperative neurological deterioration occurred.
  
  
  METHODS
  Between August 2005 and June 2009, 22 patients younger than 18 years of age with moyamoya disease were treated at Miyagi Children's Hospital. The mean patient age (+/- SD) was 8.58 +/- 4.55 years (range 2-17 years). Superficial temporal artery-middle cerebral artery bypass and indirect bypass of encephalosynangiosis between the brain surface and the temporal muscle, galea, and dura mater were performed in 35 hemispheres. Magnetic resonance imaging and MR angiography were performed before surgery, at 7 days postoperatively, and 3-6 months after surgery. A (123)I-isopropyl iodoamphetamine SPECT scan was also obtained pre- and postoperatively.
  
  
  RESULTS
  During the postoperative period, neurological deterioration was observed after 15 operations (10 cases of motor paresis, 1 of aphasia, and 4 of sensory disturbance) in 13 patients. All symptoms had resolved by the time of discharge, except in 2 patients who suffered cerebral infarction. All patients exhibited disappearance (94.3%) or reduction (5.7%) of transient ischemic attacks (TIAs) during the follow-up period. Perioperative studies revealed 2 different types of radiological findings, focal uptake decrease on SPECT indicative of cerebral ischemia due to dynamic change in cerebral hemodynamics caused by bypass flow, the so-called watershed shift, and perioperative edematous lesions on MR imaging due to cerebral hyperperfusion. The frequent occurrence of preoperative TIAs was significantly associated with watershed shift, whereas preoperative MR imaging findings and preoperative SPECT findings were not. Age at operation was the only factor significantly associated with postoperative hyperperfusion.
  
  
  CONCLUSIONS
  In young patients, moyamoya disease exhibits rapid progression, resulting in poor clinical outcome. The risk of postoperative neurological deterioration in very young moyamoya patients with frequent TIAs should be noted. The findings in this study showed that direct bypass is not completely safe in patients with moyamoya disease because it causes dynamic change in postoperative cerebral hemodynamics.
authors.affiliation: Departments of Neurosurgery, Miyagi Children's Hospital, Sendai, Japan. hayashi@nsg.med.tohoku.ac.jp
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hayashi
authors.forename: Reizo
authors.initials: R
authors.lastname: Shirane
authors.forename: Miki
authors.initials: M
authors.lastname: Fujimura
authors.forename: Teiji
authors.initials: T
authors.lastname: Tominaga
mesh_terms: D000086:Acetazolamide; D000293:Adolescent; D001037:Aphasia / Q000175:diagnosis*; D001921:Brain / Q000098:blood supply*; D001929:Brain Edema / Q000175:diagnosis*; D002533:Cerebral Angiography; D002544:Cerebral Infarction / Q000175:diagnosis*; D002648:Child; D002675:Child, Preschool; D004292:Dominance, Cerebral / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006429:Hemiplegia / Q000175:diagnosis*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis*; D018810:Magnetic Resonance Angiography; D008279:Magnetic Resonance Imaging; D008297:Male; D009072:Moyamoya Disease / Q000175:diagnosis / Q000601:surgery*; D009460:Neurologic Examination; D010291:Paresis / Q000175:diagnosis*; D011183:Postoperative Complications / Q000175:diagnosis*; D012039:Regional Blood Flow / Q000502:physiology; D012075:Remission, Spontaneous; D015427:Reperfusion Injury / Q000175:diagnosis*; D012678:Sensation Disorders / Q000175:diagnosis*; D015899:Tomography, Emission-Computed, Single-Photon; D014665:Vasodilator Agents
chemical_list: D014665:Vasodilator Agents; D000086:Acetazolamide